The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence

HIGHLIGHTS

  • who: Sonja Schiffer from the Germany Germany Germany Germany have published the Article: The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence, in the Journal: (JOURNAL)
  • what: The aim of this review is to summarize the existing evidence regarding the use of blood-based to characterize the effects of on and other pathways including platelet activation and effects. To inform the discussions in this review, searches were conducted in Medline mainly via PubMed to identify literature reporting preclinical and clinical studies of rivaroxaban and biomarkers of coagulation . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?